Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)


Open article in different language:  DE  |  FR  |  IT
Art. 32 Procedure in the event of a positive test result

1 If the test is re­peatedly re­act­ive, the blood dona­tion may not be used for trans­fu­sion or to man­u­fac­ture blood products.

2 If fur­ther con­firm­a­tion tests on blood in­ten­ded for auto­log­ous trans­fu­sion give a neg­at­ive res­ult or if the res­ults of tests car­ried out in ac­cord­ance with An­nex 5, num­ber 2.2 let­ter d de­vi­ate from the norm, the treat­ing phys­i­cian de­cides wheth­er to carry out the trans­fu­sion.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden